Selected discussion
Clinical evidence update from Journal of the American Veterinary Medical Association
Clinical Context
Peer-reviewed veterinary literature continues to shape everyday decision-making for feline patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.
What the Study Evaluated
A study published in Journal of the American Veterinary Medical Association in 2026 evaluated lorazepam reduces recurrence of urethral obstruction in male cats: a prospective, randomized, double-blinded, placebo-controlled study..
Key Findings
To determine the efficacy of lorazepam in reducing the rate of recurrence in first-time feline urethral obstruction (UO) and frequency of lower urinary tract (LUT) signs following hospitalization, as well as adverse effects of the medication. This was a prospective, randomized, double-blinded, placebo-controlled study of 80 client-owned male cats presenting to a university teaching…
Discussion thread
Follow the line down to read the conversation in order.
The study examines the use of lorazepam to potentially reduce urethral obstruction recurrence in male cats. This topic touches upon the broader context of emergency clinical assessment and triage procedures. Related coverage appears in Manual of Small Animal Surgical Emergencies by Filippo Cinti, Matteo Rossanese, and Marie Burneko.
Join this discussion
Add your reply
Share a professional insight, ask a focused question, or add relevant clinical experience.
Member participation
Log in to join the discussion
Share an answer, ask a question, reply to another professional, or mark useful contributions as helpful.